Keay Nakae
Stock Analyst at Chardan Capital
(3.89)
# 711
Out of 4,974 analysts
247
Total ratings
42.15%
Success rate
12.45%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.75 | +627.27% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $33.18 | -24.65% | 3 | Aug 13, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $60 | $44.21 | +35.72% | 2 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $6.34 | +120.82% | 20 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $29.08 | +106.36% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $4.20 | +19.05% | 13 | Aug 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.45 | +63.27% | 15 | Aug 8, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $75 | $50.36 | +48.93% | 18 | Aug 8, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 → $12 | $2.27 | +428.63% | 16 | Aug 8, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.56 | +529.50% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $452.00 | -11.50% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $14.22 | +167.23% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.84 | +498.80% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $19.36 | -69.01% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $2.85 | +601.75% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.76 | +240.91% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.23 | +12.11% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.38 | +2,028.23% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.46 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $14.39 | -58.30% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.52 | +3,768.47% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $7.58 | +625.59% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $4.75 | +110.53% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $11.18 | +682.65% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.03 | +1,162.14% | 3 | Feb 9, 2021 |
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.75
Upside: +627.27%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $33.18
Upside: -24.65%
Monopar Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $60
Current: $44.21
Upside: +35.72%
Coya Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $14
Current: $6.34
Upside: +120.82%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $29.08
Upside: +106.36%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $4.20
Upside: +19.05%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.45
Upside: +63.27%
Avidity Biosciences
Aug 8, 2025
Maintains: Buy
Price Target: $75
Current: $50.36
Upside: +48.93%
SAB Biotherapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $2.27
Upside: +428.63%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $5.56
Upside: +529.50%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $452.00
Upside: -11.50%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $14.22
Upside: +167.23%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.84
Upside: +498.80%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $19.36
Upside: -69.01%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $2.85
Upside: +601.75%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.76
Upside: +240.91%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.23
Upside: +12.11%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.38
Upside: +2,028.23%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.46
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $14.39
Upside: -58.30%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.52
Upside: +3,768.47%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $7.58
Upside: +625.59%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $4.75
Upside: +110.53%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $11.18
Upside: +682.65%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.03
Upside: +1,162.14%